Tonix Pharmaceuticals stock halted ahead of FDA approval news
Carrie Chelko, EVP and General Counsel at Jackson Financial Inc (NYSE:JXN), sold 3,000 shares of the company’s common stock on August 13, 2025. The shares were sold at a weighted average price of $95.40, for a total value of $286,200. The transaction occurred in a $6.72 billion market cap company that offers shareholders a 3.32% dividend yield. According to InvestingPro analysis, the stock is trading near its Fair Value, with management actively buying back shares.
The prices for the sales ranged from $95.39 to $95.50. Following the transaction, Chelko directly owns 71,928.10 shares of Jackson Financial Inc. InvestingPro data shows the company maintains a GOOD financial health score, with liquid assets exceeding short-term obligations. For deeper insights into insider trading patterns and 8 additional exclusive ProTips, consider accessing the comprehensive Pro Research Report available on InvestingPro.
In other recent news, Jackson Financial Inc. reported impressive financial results for the second quarter of 2025. The company exceeded expectations with an earnings per share of $4.87, surpassing the forecast of $4.64. Additionally, Jackson Financial’s revenue reached $1.94 billion, significantly beating the anticipated $1.51 billion. These results highlight the company’s strong performance during this period. The recent developments reflect positively on Jackson Financial, marking a period of financial strength. No information regarding mergers or acquisitions was reported in these updates. Analyst upgrades or downgrades have not been mentioned in the recent reports. Investors might find these developments noteworthy as they assess the company’s financial health.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.